More recently, apelin has been identified as a potential therapeutic option for diabetes due to its ability to improve insulin production, insulin sensitivity and positively regulate diabetic complications, such as diabetes related kidney hypertrophy.13,22 Additionally, apelin has been demonstrated to induce satiety and reduce body weight,23,24 making it a very attractive target for future diabetes therapy. This evidence concerns the gene APLN and diabetes mellitus.